Is this you? Create Your Porfile
Avatar

Herbert Dr Schneider

Schering AG

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Herbert Dr Schneider is active.

Explore More

Publication

Featured researches published by Herbert Dr Schneider.

Archive | 1982

Novel (2-haloergolinyl)-N'-N'-diethylurea derivatives, process for the preparation thereof, and use thereof as medicinal agents

Jean-Claude Hilscher; Wolfgang Kehr; Gerhard Sauer; Herbert Dr Schneider; Helmut Wachtel

Archive | 1982

Novel ergolinyl compounds nitrogen-substituted in the 8-position, their preparation, and use as medicinal agents

Gregor Haffer; Gerhard Sauer; Helmut Wachtel; Herbert Dr Schneider; Ulrich Eder; Hans-Peter Lorenz

Archive | 1986

3-Vinyl and 3-ethinyl-beta-carboline derivatives, their preparation and their use as medicaments

Dieter Seidelmann; Andreas Huth; Ralph Schmiechen; Rudolf Wiechert; Herbert Dr Schneider; David Norman Stephens

Archive | 1981

Neue (2-halogen-ergolinyl)-n'.n'-diethyl-harnstoffderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel

Jean-Claude Hilscher; Wolfgang Kehr; Gerhard Sauer; Herbert Dr Schneider; Helmut Wachtel

Archive | 1992

3-ARYL- ODER 3-HETARYL-(BETA)-CARBOLINE, DEREN HERSTELLUNG UND VERWENDUNG IN ARZNEIMITTELN

Andreas Huth; Dieter Seidelmann; Ralph Schmiechen; Herbert Dr Schneider; Lechoslaw Turski

Archive | 1992

Arzneimittel zur Verhinderung der Toleranzentwicklung während der Behandlung mit Benzodiazepin-Rezeptor-Bindenen Wirkstoffen Medicines used to prevent the development of tolerance during treatment with benzodiazepine-receptor-binding agents

Lechoslaw Turski; Karin Gabriele Steppuhn; Herbert Dr Schneider; David Norman Stephens

Archive | 1992

Verwendung von µ-Carbolinen als nicht-kompetitive Glutamat-Antagonisten Use of μ-carbolines as a non-competitive glutamate antagonists

Andreas Huth; Martin Krueger; Dieter Rahtz; Dieter Seidelmann; Lechoslaw Turski; Peter-Andreas Loeschmann; David-Norman Dr Stephens; Herbert Dr Schneider

Archive | 1991

Isoxazolylimidazolderivate, verfahren zu deren herstellung und deren verwendung in arzneimitteln Isoxazolylimidazolderivate, processes for their preparation and their use in medicaments

Martin Krueger; Rolf Russe; Ralph Schmiechen; Herbert Dr Schneider; Lechoslaw Turski

Archive | 1991

3-aryl- oder 3-hetaryl-(beta)-carboline, deren herstellung und verwendung in arzneimitteln 3-aryl- or 3-hetaryl (beta) carbolines, their production and use in pharmaceutical compositions

Andreas Huth; Dieter Seidelmann; Ralph Schmiechen; Herbert Dr Schneider; Lechoslaw Turski

Archive | 1991

3-aryl- or 3-hetaryl (beta) carbolines, their production and use in pharmaceutical compositions

Andreas Huth; Dieter Seidelmann; Ralph Schmiechen; Herbert Dr Schneider; Lechoslaw Turski

Explore More

Collaboration

Dive into the Herbert Dr Schneider's collaboration.

Top Co-Authors
Avatar

Andreas Huth

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Dieter Seidelmann

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Ralph Schmiechen

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Lechoslaw Turski

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Gerhard Sauer

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Helmut Wachtel

Schering AG

View shared research outputs
Top Co-Authors
Avatar

David Norman Stephens

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Martin Krueger

Schering AG

View shared research outputs
Top Co-Authors
Avatar

Gregor Haffer

Technical University of Berlin

View shared research outputs
Top Co-Authors
Avatar

Hans-Peter Lorenz

Schering AG

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge